1 ml of suspension contains 10 mg brinzolamide.
AZOPT® eye drops contain brinzolamide, a carbonic anhydrase inhibitor. AZOPT eye drops are indicated to decrease elevated intraocular pressure (IOP) in adult patients with ocular hypertension or open-angle glaucoma, as monotherapy in patients unresponsive to beta-blockers or in patients for whom beta-blockers are contraindicated, or as adjunctive therapy to beta-blockers.